APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cisplatin Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cisplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchCisplatin Injection Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Cisplatin Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Cisplatin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cisplatin Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Cisplatin Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Cisplatin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cisplatin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cisplatin Injection include Cipla, Hospira(Pfizer), Taj Pharmaceuticals, Fresenius Kabi, Lingnan Pharmacy, Hansoh Pharma, Jinzhou Jiutai Pharmaceutical, Nanjing Pharmaceutical Factory and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cisplatin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cisplatin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cisplatin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cisplatin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Cisplatin Injection Segment by Company

Cipla

Hospira(Pfizer)

Taj Pharmaceuticals

Fresenius Kabi

Lingnan Pharmacy

Hansoh Pharma

Jinzhou Jiutai Pharmaceutical

Nanjing Pharmaceutical Factory

Qilu Pharmaceutical

Luoxin

Teva

Bievalley

Yunnan Phytopharmaceutical

Cisplatin Injection Segment by Type

50ml

100ml

200ml

Cisplatin Injection Segment by Application

NSCLC

Testicular Cancer

Ovarian Cancer

Other

Cisplatin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cisplatin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cisplatin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cisplatin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cisplatin Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cisplatin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cisplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cisplatin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cisplatin Injection Industry Trends Table 2. Cisplatin Injection Industry Drivers Table 3. Cisplatin Injection Industry Opportunities and Challenges Table 4. Cisplatin Injection Industry Restraints Table 5. Global Cisplatin Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cisplatin Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cisplatin Injection Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Cisplatin Injection Sales Market Share by Manufacturers Table 9. Global Cisplatin Injection Average Sales Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Cisplatin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cisplatin Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cisplatin Injection Manufacturers, Product Type & Application Table 13. Global Cisplatin Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cisplatin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50ml Table 17. Major Manufacturers of 100ml Table 18. Major Manufacturers of 200ml Table 19. Global Cisplatin Injection Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 20. Global Cisplatin Injection Sales by Type (2021-2026) & (Tons) Table 21. Global Cisplatin Injection Sales by Type (2027-2032) & (Tons) Table 22. Global Cisplatin Injection Sales Market Share by Type (2021-2026) Table 23. Global Cisplatin Injection Sales Market Share by Type (2027-2032) Table 24. Global Cisplatin Injection Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 25. Global Cisplatin Injection Revenue by Type (2021-2026) & (Tons) Table 26. Global Cisplatin Injection Revenue by Type (2027-2032) & (Tons) Table 27. Global Cisplatin Injection Revenue Market Share by Type (2021-2026) Table 28. Global Cisplatin Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of NSCLC Table 30. Major Manufacturers of Testicular Cancer Table 31. Major Manufacturers of Ovarian Cancer Table 32. Major Manufacturers of Other Table 33. Global Cisplatin Injection Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Cisplatin Injection Sales by Application (2021-2026) & (Tons) Table 35. Global Cisplatin Injection Sales by Application (2027-2032) & (Tons) Table 36. Global Cisplatin Injection Sales Market Share by Application (2021-2026) Table 37. Global Cisplatin Injection Sales Market Share by Application (2027-2032) Table 38. Global Cisplatin Injection Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 39. Global Cisplatin Injection Revenue by Application (2021-2026) & (Tons) Table 40. Global Cisplatin Injection Revenue by Application (2027-2032) & (Tons) Table 41. Global Cisplatin Injection Revenue Market Share by Application (2021-2026) Table 42. Global Cisplatin Injection Revenue Market Share by Application (2027-2032) Table 43. Global Cisplatin Injection Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Cisplatin Injection Sales by Region (2021-2026) & (Tons) Table 45. Global Cisplatin Injection Sales Market Share by Region (2021-2026) Table 46. Global Cisplatin Injection Sales Forecasted by Region (2027-2032) & (Tons) Table 47. Global Cisplatin Injection Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Cisplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 49. North America Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 50. North America Cisplatin Injection Sales by Country (2027-2032) & (Tons) Table 51. Europe Cisplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. Europe Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 53. Europe Cisplatin Injection Sales by Country (2027-2032) & (Tons) Table 54. Asia Pacific Cisplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. Asia Pacific Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 56. Asia Pacific Cisplatin Injection Sales by Country (2027-2032) & (Tons) Table 57. South America, Middle East and Africa Cisplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 58. South America, Middle East and Africa Cisplatin Injection Sales by Country (2021-2026) & (Tons) Table 59. South America, Middle East and Africa Cisplatin Injection Sales by Country (2027-2032) & (Tons) Table 60. Global Cisplatin Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Cisplatin Injection Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Cisplatin Injection Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Cisplatin Injection Revenue Market Share by Region (2021-2026) Table 64. Global Cisplatin Injection Revenue Market Share by Region (2027-2032) Table 65. Cipla Company Information Table 66. Cipla Business Overview Table 67. Cipla Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Cipla Cisplatin Injection Product Portfolio Table 69. Cipla Recent Development Table 70. Hospira(Pfizer) Company Information Table 71. Hospira(Pfizer) Business Overview Table 72. Hospira(Pfizer) Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Hospira(Pfizer) Cisplatin Injection Product Portfolio Table 74. Hospira(Pfizer) Recent Development Table 75. Taj Pharmaceuticals Company Information Table 76. Taj Pharmaceuticals Business Overview Table 77. Taj Pharmaceuticals Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Taj Pharmaceuticals Cisplatin Injection Product Portfolio Table 79. Taj Pharmaceuticals Recent Development Table 80. Fresenius Kabi Company Information Table 81. Fresenius Kabi Business Overview Table 82. Fresenius Kabi Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Fresenius Kabi Cisplatin Injection Product Portfolio Table 84. Fresenius Kabi Recent Development Table 85. Lingnan Pharmacy Company Information Table 86. Lingnan Pharmacy Business Overview Table 87. Lingnan Pharmacy Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Lingnan Pharmacy Cisplatin Injection Product Portfolio Table 89. Lingnan Pharmacy Recent Development Table 90. Hansoh Pharma Company Information Table 91. Hansoh Pharma Business Overview Table 92. Hansoh Pharma Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Hansoh Pharma Cisplatin Injection Product Portfolio Table 94. Hansoh Pharma Recent Development Table 95. Jinzhou Jiutai Pharmaceutical Company Information Table 96. Jinzhou Jiutai Pharmaceutical Business Overview Table 97. Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Portfolio Table 99. Jinzhou Jiutai Pharmaceutical Recent Development Table 100. Nanjing Pharmaceutical Factory Company Information Table 101. Nanjing Pharmaceutical Factory Business Overview Table 102. Nanjing Pharmaceutical Factory Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Nanjing Pharmaceutical Factory Cisplatin Injection Product Portfolio Table 104. Nanjing Pharmaceutical Factory Recent Development Table 105. Qilu Pharmaceutical Company Information Table 106. Qilu Pharmaceutical Business Overview Table 107. Qilu Pharmaceutical Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Qilu Pharmaceutical Cisplatin Injection Product Portfolio Table 109. Qilu Pharmaceutical Recent Development Table 110. Luoxin Company Information Table 111. Luoxin Business Overview Table 112. Luoxin Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Luoxin Cisplatin Injection Product Portfolio Table 114. Luoxin Recent Development Table 115. Teva Company Information Table 116. Teva Business Overview Table 117. Teva Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Teva Cisplatin Injection Product Portfolio Table 119. Teva Recent Development Table 120. Bievalley Company Information Table 121. Bievalley Business Overview Table 122. Bievalley Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Bievalley Cisplatin Injection Product Portfolio Table 124. Bievalley Recent Development Table 125. Yunnan Phytopharmaceutical Company Information Table 126. Yunnan Phytopharmaceutical Business Overview Table 127. Yunnan Phytopharmaceutical Cisplatin Injection Sales (Tons), Price (US$/Kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Yunnan Phytopharmaceutical Cisplatin Injection Product Portfolio Table 129. Yunnan Phytopharmaceutical Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Cisplatin Injection Distributors List Table 133. Cisplatin Injection Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Cisplatin Injection Product Image Figure 2. Global Cisplatin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cisplatin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cisplatin Injection Sales (2021-2032) & (Tons) Figure 5. Global Cisplatin Injection Average Price (US$/Kg) & (2021-2032) Figure 6. Global Top 5 and 10 Cisplatin Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50ml Image Figure 9. 100ml Image Figure 10. 200ml Image Figure 11. Global Cisplatin Injection Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 12. Global Cisplatin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Cisplatin Injection Sales Market Share by Type (2021-2032) Figure 14. Global Cisplatin Injection Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 15. Global Cisplatin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Cisplatin Injection Revenue Market Share by Type (2021-2032) Figure 17. NSCLC Image Figure 18. Testicular Cancer Image Figure 19. Ovarian Cancer Image Figure 20. Other Image Figure 21. Global Cisplatin Injection Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Cisplatin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Cisplatin Injection Sales Market Share by Application (2021-2032) Figure 24. Global Cisplatin Injection Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 25. Global Cisplatin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Cisplatin Injection Revenue Market Share by Application (2021-2032) Figure 27. North America Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 28. North America Cisplatin Injection Sales Market Share by Country (2021-2032) Figure 29. U.S. Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Canada Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 31. Mexico Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 32. Europe Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 33. Europe Cisplatin Injection Sales Market Share by Country (2021-2032) Figure 34. Germany Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 35. France Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 36. U.K. Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Italy Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 38. Netherlands Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Asia Pacific Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 40. Asia Pacific Cisplatin Injection Sales Market Share by Country (2021-2032) Figure 41. China Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 42. Japan Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 43. South Korea Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 44. Southeast Asia Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 45. India Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 46. Australia Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South America, Middle East and Africa Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 48. South America, Middle East and Africa Cisplatin Injection Sales Market Share by Country (2021-2032) Figure 49. Brazil Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 50. South Africa Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 51. Saudi Arabia Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Turkey Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Argentina Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 54. UAE Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 55. Egypt Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 56. Chile Cisplatin Injection Sales and Growth Rate (2021-2032) & (Tons) Figure 57. Global Cisplatin Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Cisplatin Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Cisplatin Injection Revenue (2021-2032) & (US$ Million) Figure 60. North America Cisplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Cisplatin Injection Revenue (2021-2032) & (US$ Million) Figure 62. Europe Cisplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Cisplatin Injection Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Cisplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Cisplatin Injection Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Cisplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Cisplatin Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Cisplatin Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 50ml
  • 100ml
  • 200ml
Applications
  • NSCLC
  • Testicular Cancer
  • Ovarian Cancer
  • Other
Companies covered
  • Cipla
  • Hospira(Pfizer)
  • Taj Pharmaceuticals
  • Fresenius Kabi
  • Lingnan Pharmacy
  • Hansoh Pharma
  • Jinzhou Jiutai Pharmaceutical
  • Nanjing Pharmaceutical Factory
  • Qilu Pharmaceutical
  • Luoxin
  • Teva
  • Bievalley
  • Yunnan Phytopharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cisplatin Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cisplatin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cisplatin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cisplatin Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cisplatin Injection Market Dynamics
  1. 2.1 Cisplatin Injection Industry Trends
  2. 2.2 Cisplatin Injection Industry Drivers
  3. 2.3 Cisplatin Injection Industry Opportunities and Challenges
  4. 2.4 Cisplatin Injection Industry Restraints
3 Cisplatin Injection Market by Manufacturers
  1. 3.1 Global Cisplatin Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cisplatin Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cisplatin Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cisplatin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cisplatin Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cisplatin Injection Manufacturers, Product Type & Application
  7. 3.7 Global Cisplatin Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cisplatin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cisplatin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cisplatin Injection Tier 1, Tier 2, and Tier 3
4 Cisplatin Injection Market by Type
  1. 4.1 Cisplatin Injection Type Introduction
  2. 4.1.1 50ml
  3. 4.1.2 100ml
  4. 4.1.3 200ml
  5. 4.2 Global Cisplatin Injection Sales by Type
  6. 4.2.1 Global Cisplatin Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cisplatin Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Cisplatin Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Cisplatin Injection Revenue by Type
  10. 4.3.1 Global Cisplatin Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Cisplatin Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Cisplatin Injection Revenue Market Share by Type (2021-2032)
5 Cisplatin Injection Market by Application
  1. 5.1 Cisplatin Injection Application Introduction
  2. 5.1.1 NSCLC
  3. 5.1.2 Testicular Cancer
  4. 5.1.3 Ovarian Cancer
  5. 5.1.4 Other
  6. 5.2 Global Cisplatin Injection Sales by Application
  7. 5.2.1 Global Cisplatin Injection Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Cisplatin Injection Sales by Application (2021-2032)
  9. 5.2.3 Global Cisplatin Injection Sales Market Share by Application (2021-2032)
  10. 5.3 Global Cisplatin Injection Revenue by Application
  11. 5.3.1 Global Cisplatin Injection Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Cisplatin Injection Revenue by Application (2021-2032)
  13. 5.3.3 Global Cisplatin Injection Revenue Market Share by Application (2021-2032)
6 Global Cisplatin Injection Sales by Region
  1. 6.1 Global Cisplatin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cisplatin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Cisplatin Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Cisplatin Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cisplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cisplatin Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cisplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cisplatin Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cisplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cisplatin Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cisplatin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cisplatin Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cisplatin Injection Revenue by Region
  1. 7.1 Global Cisplatin Injection Revenue by Region
  2. 7.1.1 Global Cisplatin Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cisplatin Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Cisplatin Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Cisplatin Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cisplatin Injection Revenue (2021-2032)
  8. 7.2.2 North America Cisplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cisplatin Injection Revenue (2021-2032)
  11. 7.3.2 Europe Cisplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cisplatin Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cisplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cisplatin Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cisplatin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cipla
  2. 8.1.1 Cipla Company Information
  3. 8.1.2 Cipla Business Overview
  4. 8.1.3 Cipla Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cipla Cisplatin Injection Product Portfolio
  6. 8.1.5 Cipla Recent Developments
  7. 8.2 Hospira(Pfizer)
  8. 8.2.1 Hospira(Pfizer) Company Information
  9. 8.2.2 Hospira(Pfizer) Business Overview
  10. 8.2.3 Hospira(Pfizer) Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hospira(Pfizer) Cisplatin Injection Product Portfolio
  12. 8.2.5 Hospira(Pfizer) Recent Developments
  13. 8.3 Taj Pharmaceuticals
  14. 8.3.1 Taj Pharmaceuticals Company Information
  15. 8.3.2 Taj Pharmaceuticals Business Overview
  16. 8.3.3 Taj Pharmaceuticals Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Taj Pharmaceuticals Cisplatin Injection Product Portfolio
  18. 8.3.5 Taj Pharmaceuticals Recent Developments
  19. 8.4 Fresenius Kabi
  20. 8.4.1 Fresenius Kabi Company Information
  21. 8.4.2 Fresenius Kabi Business Overview
  22. 8.4.3 Fresenius Kabi Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Fresenius Kabi Cisplatin Injection Product Portfolio
  24. 8.4.5 Fresenius Kabi Recent Developments
  25. 8.5 Lingnan Pharmacy
  26. 8.5.1 Lingnan Pharmacy Company Information
  27. 8.5.2 Lingnan Pharmacy Business Overview
  28. 8.5.3 Lingnan Pharmacy Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lingnan Pharmacy Cisplatin Injection Product Portfolio
  30. 8.5.5 Lingnan Pharmacy Recent Developments
  31. 8.6 Hansoh Pharma
  32. 8.6.1 Hansoh Pharma Company Information
  33. 8.6.2 Hansoh Pharma Business Overview
  34. 8.6.3 Hansoh Pharma Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hansoh Pharma Cisplatin Injection Product Portfolio
  36. 8.6.5 Hansoh Pharma Recent Developments
  37. 8.7 Jinzhou Jiutai Pharmaceutical
  38. 8.7.1 Jinzhou Jiutai Pharmaceutical Company Information
  39. 8.7.2 Jinzhou Jiutai Pharmaceutical Business Overview
  40. 8.7.3 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Jinzhou Jiutai Pharmaceutical Cisplatin Injection Product Portfolio
  42. 8.7.5 Jinzhou Jiutai Pharmaceutical Recent Developments
  43. 8.8 Nanjing Pharmaceutical Factory
  44. 8.8.1 Nanjing Pharmaceutical Factory Company Information
  45. 8.8.2 Nanjing Pharmaceutical Factory Business Overview
  46. 8.8.3 Nanjing Pharmaceutical Factory Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nanjing Pharmaceutical Factory Cisplatin Injection Product Portfolio
  48. 8.8.5 Nanjing Pharmaceutical Factory Recent Developments
  49. 8.9 Qilu Pharmaceutical
  50. 8.9.1 Qilu Pharmaceutical Company Information
  51. 8.9.2 Qilu Pharmaceutical Business Overview
  52. 8.9.3 Qilu Pharmaceutical Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qilu Pharmaceutical Cisplatin Injection Product Portfolio
  54. 8.9.5 Qilu Pharmaceutical Recent Developments
  55. 8.10 Luoxin
  56. 8.10.1 Luoxin Company Information
  57. 8.10.2 Luoxin Business Overview
  58. 8.10.3 Luoxin Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Luoxin Cisplatin Injection Product Portfolio
  60. 8.10.5 Luoxin Recent Developments
  61. 8.11 Teva
  62. 8.11.1 Teva Company Information
  63. 8.11.2 Teva Business Overview
  64. 8.11.3 Teva Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Teva Cisplatin Injection Product Portfolio
  66. 8.11.5 Teva Recent Developments
  67. 8.12 Bievalley
  68. 8.12.1 Bievalley Company Information
  69. 8.12.2 Bievalley Business Overview
  70. 8.12.3 Bievalley Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Bievalley Cisplatin Injection Product Portfolio
  72. 8.12.5 Bievalley Recent Developments
  73. 8.13 Yunnan Phytopharmaceutical
  74. 8.13.1 Yunnan Phytopharmaceutical Company Information
  75. 8.13.2 Yunnan Phytopharmaceutical Business Overview
  76. 8.13.3 Yunnan Phytopharmaceutical Cisplatin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Yunnan Phytopharmaceutical Cisplatin Injection Product Portfolio
  78. 8.13.5 Yunnan Phytopharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cisplatin Injection Value Chain Analysis
  2. 9.1.1 Cisplatin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cisplatin Injection Production Mode & Process
  6. 9.2 Cisplatin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cisplatin Injection Distributors
  9. 9.2.3 Cisplatin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst